BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25743748)

  • 21. In silico prediction of genotoxicity.
    Wichard JD
    Food Chem Toxicol; 2017 Aug; 106(Pt B):595-599. PubMed ID: 27979779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
    Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
    Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
    Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A practical application of two in silico systems for identification of potentially mutagenic impurities.
    Greene N; Dobo KL; Kenyon MO; Cheung J; Munzner J; Sobol Z; Sluggett G; Zelesky T; Sutter A; Wichard J
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):335-49. PubMed ID: 25980641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of published DNA reactivity alerts.
    Myden A; Guesne SJ; Cayley A; Williams RV
    Regul Toxicol Pharmacol; 2017 Aug; 88():77-86. PubMed ID: 28549899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An assessment of mutagenicity of chemical substances by (quantitative) structure-activity relationship.
    Honma M
    Genes Environ; 2020; 42():23. PubMed ID: 32626544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.
    Jolly R; Ahmed KB; Zwickl C; Watson I; Gombar V
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):388-97. PubMed ID: 25656493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of structure-activity relationship and artificial intelligence systems to improve in silico prediction of ames test mutagenicity.
    Mazzatorta P; Tran LA; Schilter B; Grigorov M
    J Chem Inf Model; 2007; 47(1):34-8. PubMed ID: 17238246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of aromatic amines with different purities and different solvent vehicles in the Ames test.
    Harding AP; Popelier PL; Harvey J; Giddings A; Foster G; Kranz M
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):244-50. PubMed ID: 25542092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of In Silico Methods for Regulatory Toxicological Assessment of Pharmaceutical Impurities.
    Kovarich S; Cappelli CI
    Methods Mol Biol; 2022; 2425():537-560. PubMed ID: 35188646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practice of expert review by read-across using QSAR Toolbox.
    Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
    Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutagenicity assessment of two potential impurities in preparations of 5-amino-2,4,6 triiodoisophthalic acid, a key intermediate in the synthesis of the iodinated contrast agent iopamidol.
    Rossi S; Bussi S; Bonafè R; Incardona C; Vurro E; Visigalli M; Buonsanti F; Fretta R
    Mutat Res Genet Toxicol Environ Mutagen; 2024 Jan; 893():503720. PubMed ID: 38272634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of In Silico Models for Mutagenicity Prediction of Food Contact Materials.
    Van Bossuyt M; Van Hoeck E; Raitano G; Vanhaecke T; Benfenati E; Mertens B; Rogiers V
    Toxicol Sci; 2018 Jun; 163(2):632-638. PubMed ID: 29579255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of quantitative structure-activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge Project.
    Honma M; Kitazawa A; Cayley A; Williams RV; Barber C; Hanser T; Saiakhov R; Chakravarti S; Myatt GJ; Cross KP; Benfenati E; Raitano G; Mekenyan O; Petkov P; Bossa C; Benigni R; Battistelli CL; Giuliani A; Tcheremenskaia O; DeMeo C; Norinder U; Koga H; Jose C; Jeliazkova N; Kochev N; Paskaleva V; Yang C; Daga PR; Clark RD; Rathman J
    Mutagenesis; 2019 Mar; 34(1):3-16. PubMed ID: 30357358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico assessment of chemical mutagenesis in comparison with results of Salmonella microsome assay on 909 chemicals.
    Hayashi M; Kamata E; Hirose A; Takahashi M; Morita T; Ema M
    Mutat Res; 2005 Dec; 588(2):129-35. PubMed ID: 16257575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
    Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
    Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the utility of common arguments used in expert review of in silico predictions as part of ICH M7 assessments.
    Cayley AN; Foster RS; Brigo A; Muster W; Musso A; Kenyon MO; Parris P; White AT; Cohen-Ohana M; Nudelman R; Glowienke S
    Regul Toxicol Pharmacol; 2023 Oct; 144():105490. PubMed ID: 37659712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
    Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
    Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of in silico systems for ames test mutagenicity prediction: scope and limitations.
    Hillebrecht A; Muster W; Brigo A; Kansy M; Weiser T; Singer T
    Chem Res Toxicol; 2011 Jun; 24(6):843-54. PubMed ID: 21534561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.